Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China
Open Access
Abstract
Objectives This study aims to investigate the diagnostic value of heparin-binding protein (HBP) in sepsis and develop a sepsis diagnostic model incorporating HBP with key biomarkers and disease-related scores for rapid, and accurate diagnosis of sepsis in the intensive care unit (ICU). Design Clinical retrospective cross-sectional study. Setting A comprehensive teaching tertiary hospital in China. Participants Adult patients (aged ≥18 years) who underwent HBP testing or whose blood samples were collected when admitted to the ICU. Main outcome measures HBP, C reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC), interleukin-6 (IL-6), lactate (LAC), Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) score were recorded. Results Between March 2019 and December 2021, 326 patients were enrolled in this study. The patients were categorised into a non-infection group (control group), infection group, sepsis group and septic shock group based on the final diagnosis. The HBP levels in the sepsis group and septic shock group were 45.7 and 69.0 ng/mL, respectively, which were significantly higher than those in the control group (18.0 ng/mL) and infection group (24.0 ng/mL) (pConclusions HBP could serve as a biomarker for the diagnosis of sepsis in the ICU. Compared with single indicators, the sepsis diagnostic model constructed using HBP, PCT, CRP, IL-6 and SOFA further enhanced the diagnostic performance of sepsis.Keywords
This publication has 33 references indexed in Scilit:
- A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitisScientific Reports, 2023
- Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: A multicenter, prospective studyClinica Chimica Acta, 2022
- Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)European Journal of Clinical Microbiology & Infectious Diseases, 2021
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudyThe Lancet, 2020
- Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3Journal of Clinical Laboratory Analysis, 2019
- Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patientsDiagnostic Microbiology and Infectious Disease, 2016
- Heparin-Binding Protein Measurement Improves the Prediction of Severe Infection With Organ Dysfunction in the Emergency DepartmentCritical Care Medicine, 2015
- Heparin-Binding Protein: A Diagnostic Biomarker of Urinary Tract Infection in AdultsOpen Forum Infectious Diseases, 2014
- Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort studyInflammation Research, 2011
- Heparin‐Binding Protein: An Early Marker of Circulatory Failure in SepsisClinical Infectious Diseases, 2009